US US · App #88822055
Owned by
Celgene CorporationApplication date
2020-03-05
Registration date
—
Published date
—
First use date
—
Renewal date
—
Expiry date
—
Kind of mark
Trademark
Mark feature
Word
USPTO flags:Standard charsITU
NICE Classes
5Pharmaceuticals
Domestic Classes
Jurisdiction-specific classifications outside WIPO 1-45 (e.g. US old classes).
006018044046051052
Current owners
Applicants
- Celgene Corporation
Correspondence
- [MARILYN F. KELLY] BRISTOL-MYERS SQUIBB COMPANY
Activity Summary
Oppositions
0
P 0 · D 0
Assignments
0
Security: 0
Renewals
0
Prosecution events
8
History Timeline
8 events- 2020-12-10PHABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND— Code :MAB2 - Type: E
- 2020-12-10PHABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE— Code :ABN2 - Type: O
- 2020-05-29PHNOTIFICATION OF NON-FINAL ACTION E-MAILED— Code :GNRN - Type: O
- 2020-05-29PHNON-FINAL ACTION E-MAILED— Code :GNRT - Type: F
- 2020-05-29PHNON-FINAL ACTION WRITTEN— Code :CNRT - Type: R
- 2020-05-26PHASSIGNED TO EXAMINER— Code :DOCK - Type: D
- 2020-03-11PHNEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM— Code :NWOS - Type: I
- 2020-03-09PHNEW APPLICATION ENTERED IN TRAM— Code :NWAP - Type: I